Elanco Animal Health Inc (FRA:5EA)
€ 15.556 -0.1 (-0.64%) Market Cap: 7.71 Bil Enterprise Value: 12.68 Bil PE Ratio: 0 PB Ratio: 1.39 GF Score: 66/100

Aratana Therapeutics, Inc., Elanco Animal Health Incorporated - M&A Call Transcript

Apr 26, 2019 / 01:00PM GMT
Release Date Price: €28.63
Operator

Good morning. My name is Amy, and I will be your conference operator today. At this time, I would like to welcome everyone to Elanco strategic investment update. (Operator Instructions) Jim Greffet, Head of Investor Relations, you may begin your conference.

Jim Greffet
Elanco Animal Health Incorporated - Head of IR

Thanks, Amy. Good morning. Thank for joining us as we announced important strategic investments for Elanco. I'm Jim Greffet, Head of Investor Relation. Joining me are Jeff Simmons, our President and Chief Executive Officer; Todd Young, our Chief Financial Officer; Aaron Schacht, Executive Vice President, Innovation, Regulatory and Business Development; and Katy Grissom from Investor Relations.

During this conference call, we anticipate making projections and forward-looking statements that are based on management's current expectations, but actual results may differ materially due to various factors. For example, our results may be affected by competitive developments, the timing and success of new product launches, regulatory and legal

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot